Categories: Chemistry

New Synthetic Molecules (SyAMs) Mimic Antibodies

Synthetic Molecules Mimic Antibodies

Credit: Yale University

Researchers from Yale University have created the first synthetic molecules that have both the targeting and response functions of antibodies.

The new molecules — synthetic antibody mimics (SyAMs) — attach themselves simultaneously to disease cells and disease-fighting cells. The result is a highly targeted immune response, similar to the action of natural human antibodies.

“Unlike antibodies, however, our molecules are synthetic organic compounds that are approximately one-twentieth the size of antibodies,” said David A. Spiegel, a professor of chemistry at Yale whose lab developed the molecules. “They are unlikely to cause unwanted immune reactions due to their structure, are thermally stable, and have the potential to be administered orally, just like traditional, small-molecule drugs.”

Spiegel and his team describe the research in a paper published online on December 16 by the Journal of the American Chemical Society.

Credit: Yale University

The paper looks specifically at SyAM molecules used to attack prostate cancer. Called SyAM-Ps, they work first by recognizing cancer cells and binding with a specific protein on their surface. Next, they also bind with a receptor on an immune cell. This induces a targeted response that leads to the destruction of the cancer cell.

Spiegel said the process of synthesizing and optimizing the structure of the molecules required considerable time and effort. “We now know that synthetic molecules of intermediate size possess perhaps the most important functional properties of antibodies — targeting and stimulation of immune cells,” he said.

“It’s also noteworthy that molecules of such a small size can bring together two objects as enormous as cells, and trigger a specific functional response, entirely as a result of specific receptor interactions,” Spiegel added.

Beyond their potential for treating prostate cancer, SyAMs may have applications for treating other forms of cancer, HIV, and various bacterial diseases.

Reference: “Chemically Synthesized Molecules with the Targeting and Effector Functions of Antibodies” by Patrick J. McEnaney, Kelly J. Fitzgerald, Andrew X. Zhang, Eugene F. Douglass, Jr., Weifang Shan, Aaron Balog, Mariya D. Kolesnikova and David A. Spiegel, 16 December 2014, Journal of the American Chemical Society.
DOI: 10.1021/ja509513c

Share
By
Jim Shelton, Yale University

Recent Posts

A New Hope for Sepsis Treatments: Anticancer Drugs

Research conducted by the IGC shows that these drugs can control inflammation, making them potential…

February 4, 2023

Quantum Materials Unveiled: A New X-Ray Imaging Technique

Using light to create transient phases in quantum materials is a novel method for engineering…

February 4, 2023

What Age Do People Sleep the Least?

A new study conducted by researchers from University College London, the University of East Anglia,…

February 3, 2023

How To Shelter From a Nuclear Explosion

Simulations reveal the destructive power of blast waves and the best places to take shelter.…

February 3, 2023

Is There Life on Saturn’s Icy Moon Enceladus? A Future Space Mission Could Provide Answers

Enceladus, encased in a thick ice shell and surrounded by a vast ocean, is a…

February 3, 2023

A Historic Discovery: Archaeologists Uncover Oldest Known Projectile Points in the Americas

Oregon State University archaeologists have made a historic discovery in Idaho by uncovering projectile points…

February 3, 2023